Vyteris Inc.
13-01 Pollitt Drive
Fair Lawn,
NJ 07410
United States - Map
Phone: 201-703-2299
Fax: 201-703-2295
Web Site: http://www.vyteris.com
| Vyteris, Inc. develops systems to transdermally deliver peptide and small molecule drugs. Its Smart Patch transdermal technology is used to deliver a peptide molecule in humans without the use of needles. The company offers LidoSite, a topical delivery system, indicated for use on normal intact skin to provide local anesthesia prior to needle stick procedures, such as venipunctures, injections, and intravenous therapies for arthritis and oncology patients, as well as superficial dermatological procedures. It is also developing products using its Smart Patch transdermal technology for female infertility treatment, migraine treatment, pain management, and topical anesthetic applications. Vyteris has a license and development agreement with Ferring Pharmaceuticals, Inc. to develop a product for female infertility treatment; and strategic partnership agreement with Zealand Pharma A/S to apply the companys technology to the controlled transdermal delivery of Zealand Pharma's peptide optimization technology. The company was formerly known as Vyteris Holdings (Nevada), Inc. Vyteris was founded in 2000 and is headquartered in Fair Lawn, New Jersey. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Haro Hartounian Ph.D., 49
Chief Exec. Officer, Pres |
$
343.00K | N/A | Mr. Joseph N. Himy CPA, 39
Chief Financial Officer and Principal Accounting Officer |
$
219.00K | N/A | Mr. David T. DiGiacinto , 55
Sec., Director, Member of Compensation Committee, Member of Nominating & Corp. Governance Committee |
$
24.00K | N/A | Mr. Michael Reidy Ph.D.,
VP of Research |
$
274.00K | N/A | Dr. Ashutosh Sharma Ph.D.,
Chief Strategic Officer and Exec. VP |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
Profile
